首页> 外文期刊>Nephron >Association between Neopterin and Carotid Intima-Media Thickness in Hemodialysis Patients
【24h】

Association between Neopterin and Carotid Intima-Media Thickness in Hemodialysis Patients

机译:血透患者新蝶呤与颈动脉内膜中层厚度的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Atherosclerotic lesions are heavily infiltrated by macrophages. Neopterin can be used as a marker of the activity of macrophages. Serum neopterin levels were elevated in non-renal patients with atherosclerosis. The intima-media thickness (IMT) of the carotid arteries in hemodialysis patients was significantly higher than in control subjects. In this study, we measured serum neopterin levels in hemodialysis patients and evaluated a possible correlation between neopterin levels and carotid IMT. Patients and Methods: Thirty-seven hemodialysis patients (26 male/11 female, mean age 47 +- 15 years) and 12 healthy subjects (8 male/4 female, mean age 43 +- 10 years) were included in this study. Serum neopterin levels were measured by using a commercial ELISA kit. Carotid IMT of the subjects were measured by high-resolution B-mode ultrasonography. Results: Carotid IMT values were 1.04 +- 0.29 and 0.77 +- 0.25 mm in hemodialysis patients and healthy controls, respectively (p < 0.01). Serum neopterin levels were 110.9 +-19.1 and 3.8 +- 2.3 ng/ml in hemodialysis patients and healthy controls, respectively (p < 0.01). Serum neopterin levels were 103.2 +- 21.3 ng/ml in hemodialysis patients with IMT<1 mm (n = 15), and 116.7 +- 15.4 ng/ml in hemodialysis patients with IMT > 1 mm (n = 22) (p < 0.05). Moreover, there was a significant correlation between serum neopterin levels and carotid IMT (p < 0.05, r = 0.363). Conclusion: Our findings suggest that neopterin could be associated with the severity of carotid atherosclerosis in hemodialysis patients.
机译:背景:动脉粥样硬化病变被巨噬细胞浸润。新蝶呤可用作巨噬细胞活性的标志物。非肾动脉粥样硬化患者血清新蝶呤水平升高。血液透析患者的颈动脉内膜中层厚度(IMT)明显高于对照组。在这项研究中,我们测量了血液透析患者的血清新蝶呤水平,并评估了新蝶呤水平与颈动脉IMT之间的可能相关性。患者和方法:本研究包括了37例血液透析患者(26例男性/ 11名女性,平均年龄47±15岁)和12例健康受试者(8例男性/ 4个女性,平均年龄43±10岁)。血清新蝶呤水平通过使用商用ELISA试剂盒测量。受试者的颈动脉IMT通过高分辨率B型超声检查。结果:血液透析患者和健康对照组的颈动脉IMT值分别为1.04±0.29和0.77±0.25 mm(p <0.01)。血液透析患者和健康对照组的血清新蝶呤水平分别为110.9±-19.1和3.8±2.3 ng / ml(p <0.01)。 IMT <1 mm(n = 15)的血液透析患者的血清新蝶呤水平为103.2±21.3 ng / ml,IMT> 1 mm(n = 22)的血液透析患者的血清新蝶呤水平为116.7±15.4 ng / ml(p <0.05 )。此外,血清新蝶呤水平与颈动脉IMT之间存在显着相关性(p <0.05,r = 0.363)。结论:我们的发现表明,新蝶呤可能与血液透析患者的颈动脉粥样硬化的严重程度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号